非酒精性脂肪肝(Nonalcoholic Fatty Liver Disease,NAFLD)是指酒精和其它明确的损肝因素之外所致的肝细胞内脂肪过度沉积引发的代谢应激性肝脏损伤。非酒精性脂肪性肝炎(Nonalcoholic Steatohepatitis,NASH)是NAFLD进展而来的严重慢性肝脏疾病,流行病学数据显示,15%～25%的NAFLD患者最终会发展为NASH。 全球平均每3个人中就...
Non-alcoholic steatohepatitis is a chronic disease in which accumulated fat in liver cells causes liver inflammation. NASH 和NAFL最大的区别就在于NASH有"炎症"inflammation NASH may gradually progress to scarring of the liver and more serious chronic...
aNon-alcoholic fatty liver disease (NAFLD) is characterized by an excessive accumulation of fatty acids and triglycerides within the cytoplasm of the hepatocytes of non-alcohol users. The natural history varies according to the initial histological diagnosis. A current consideration is that cryptogenic ...
非酒精性脂肪性肝病（nonalcoholic fatty liver desease NAFLD） 是一种肝组织病理学改变与酒精性肝病相类似但无过量饮酒史的临床综合征。NAFLD疾病谱包括单纯性脂肪肝、非酒精性脂肪性肝炎（nonalcoholic steatohepatitis NASH）和脂肪性肝硬化三种主要类型。流行病学 NAFLD常合并肥胖和或2型糖尿病、高脂血症。NAFLD...
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder both in western industrialized countries and in developing countries. The most common causes of NAFLD are obesity, diabetes, and high cholesterol levels. Despite the increasing prevalence of NAFLD, the therapeutic agents are...
1.Therapeutic effect of weight loss combining bicyclol on primary nonalcoholic fatty liver diseases;减轻体重联合百塞诺治疗非酒精性脂肪性肝病疗效分析 2.Objetive:To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases(NAFLD).目的:研究健脾补肾中...
NAFLD is a collective term that encompasses non-alcoholic hepatic steatosis (modest lipid accumulation within the liver) to non-alcoholic steato-hepatitis (NASH), which often precedes liver fibrosis, cirrhosis, and hepatocellular carcinoma (Fargion et al., 2014). ...
Treatment of non-alcoholic fatty liver disease by Qianggan Capsule (强肝胶囊)[J] . Li Li,Xiao-jin Zhang,Yu Lan,Le Xu,Xue-zhi Zhang,Hua-hong Wang.Chinese Journal of Integrative Medicine . 2010 (1)Li Li,Xiao-jin Zhang,Yu Lan,Le Xu,Xue-zhi Zhang,Hua-hong Wang.Treatment of non-...
2.Objective:To detect and analyze the effects of medical intervention for non-alcoholic fatty liver disease(NAFLD) using reverse transcription(RT) and real-time quantitative polymerase chain reaction(real-time qPCR).目的:以逆转录(RT)和实时定量聚合酶链式反应(Real-tim e qPCR)检测和分析药物对于非酒精...
Cardiovascular disease (CVD) is strongly associated with type 2 diabetes (T2DM), chronic kidney disease (CKD), and nonalcoholic fatty liver disease (NAFLD). Through significant investments in novel technology, the Cleveland HeartLab is fostering innovation to detect these conditions in their early sta...